HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
暂无分享,去创建一个
M. Kurosumi | D. Allred | J. Ranger-Moore | S. Kurozumi | H. Matsumoto | Kenichi Inoue | J. Horiguchi | T. Oyama | H. Nitta | Eslie Dennis | I. Takeyoshi | M. Padilla | D. Craig Allred